Cite
Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
MLA
Tao, M. H., et al. “Oral Bisphosphonate Use and Lung Cancer Incidence among Postmenopausal Women.” Annals of Oncology, vol. 29, no. 6, June 2018, pp. 1476–85. EBSCOhost, https://doi.org/10.1093/annonc/mdy097.
APA
Tao, M. H., Chen, S., Freudenheim, J. L., Cauley, J. A., Johnson, K. C., Mai, X., Sarto, G. E., Wakelee, H., Boffetta, P., & Wactawski-Wende, J. (2018). Oral bisphosphonate use and lung cancer incidence among postmenopausal women. Annals of Oncology, 29(6), 1476–1485. https://doi.org/10.1093/annonc/mdy097
Chicago
Tao, M H, S Chen, J L Freudenheim, J A Cauley, K C Johnson, X Mai, G E Sarto, H Wakelee, P Boffetta, and J Wactawski-Wende. 2018. “Oral Bisphosphonate Use and Lung Cancer Incidence among Postmenopausal Women.” Annals of Oncology 29 (6): 1476–85. doi:10.1093/annonc/mdy097.